These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D. Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824 [TBL] [Abstract][Full Text] [Related]
6. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer]. Chen YN; Gu Y Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632 [TBL] [Abstract][Full Text] [Related]
7. Role of lymphangiogenic factors in tumor metastasis. He Y; Karpanen T; Alitalo K Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646 [TBL] [Abstract][Full Text] [Related]
9. Tumor-induced lymphangiogenesis: a target for cancer therapy? Thiele W; Sleeman JP J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404 [TBL] [Abstract][Full Text] [Related]
11. Targeting lymphangiogenesis to prevent tumour metastasis. Achen MG; Mann GB; Stacker SA Br J Cancer; 2006 May; 94(10):1355-60. PubMed ID: 16641900 [TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenic growth factors, receptors and therapies. Lohela M; Saaristo A; Veikkola T; Alitalo K Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864 [TBL] [Abstract][Full Text] [Related]
13. Molecular control of lymphatic metastasis. Achen MG; Stacker SA Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975 [TBL] [Abstract][Full Text] [Related]
14. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis. Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479 [TBL] [Abstract][Full Text] [Related]
15. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927 [TBL] [Abstract][Full Text] [Related]
16. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Ny A; Koch M; Vandevelde W; Schneider M; Fischer C; Diez-Juan A; Neven E; Geudens I; Maity S; Moons L; Plaisance S; Lambrechts D; Carmeliet P; Dewerchin M Blood; 2008 Sep; 112(5):1740-9. PubMed ID: 18474726 [TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis and lymphatic function in periodontal disease. Berggreen E; Wiig H J Dent Res; 2013 Dec; 92(12):1074-80. PubMed ID: 24029591 [TBL] [Abstract][Full Text] [Related]
18. New insights into the molecular control of the lymphatic vascular system and its role in disease. Cueni LN; Detmar M J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of lymphangiogenesis in health and disease. Alitalo K; Carmeliet P Cancer Cell; 2002 Apr; 1(3):219-27. PubMed ID: 12086857 [TBL] [Abstract][Full Text] [Related]